John Trojanowski on Drug evaluation: (R)-flurbiprofen--an enantiomer of flurbiprofen for the treatment of Alzheimer's disease.
COMMENT This is an exciting story to keep an eye on for outcome of the phase III trial. It would be great to see successful translation of basic science research into more effective therapies for patients. 0 trojanow